ストックスクリーナーアプリを入手
25.86
0.78%
0.20
アフターアワーズ：
25.86
Immunovant Inc (IMVT) 最新ニュース
Wells Fargo & Company Issues Pessimistic Forecast for Immunovant (NASDAQ:IMVT) Stock Price - Defense World
Wells Fargo & Company Lowers Immunovant (NASDAQ:IMVT) Price Target to $45.00 - MarketBeat
Immunovant, Inc. (NASDAQ:IMVT) Receives $47.89 Consensus Target Price from Analysts - MarketBeat
Immunovant (NASDAQ:IMVT) Shares Down 5.2%Should You Sell? - MarketBeat
Immunovant's SWOT analysis: biotech stock poised for growth in Graves' disease - Investing.com India
State Street Corp Buys 303,386 Shares of Immunovant, Inc. (NASDAQ:IMVT) - MarketBeat
(IMVT) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Head to Head Contrast: Jasper Therapeutics (NASDAQ:JSPR) versus Immunovant (NASDAQ:IMVT) - Defense World
The Manufacturers Life Insurance Company Has $1.05 Million Stock Holdings in Immunovant, Inc. (NASDAQ:IMVT) - Defense World
Charles Schwab Investment Management Inc. Has $15.75 Million Stake in Immunovant, Inc. (NASDAQ:IMVT) - MarketBeat
Redmile Group LLC Decreases Stake in Immunovant, Inc. (NASDAQ:IMVT) - MarketBeat
Immunovant's SWOT analysis: stock undervalued amid promising Graves' disease treatment - Investing.com UK
Immunovant director Atul Pande sells shares for $221,185 By Investing.com - Investing.com Canada
Immunovant director Atul Pande sells shares for $221,185 - Investing.com
(IMVT) Investment Analysis and Advice - Stock Traders Daily
Bamco Inc. NY Sells 25,000 Shares of Immunovant, Inc. (NASDAQ:IMVT) - MarketBeat
Erste Asset Management GmbH Makes New Investment in Immunovant, Inc. (NASDAQ:IMVT) - MarketBeat
Baker BROS. Advisors LP Raises Holdings in Immunovant, Inc. (NASDAQ:IMVT) - MarketBeat
Fmr LLC Increases Stock Position in Immunovant, Inc. (NASDAQ:IMVT) - MarketBeat
Intech Investment Management LLC Buys Shares of 21,825 Immunovant, Inc. (NASDAQ:IMVT) - MarketBeat
Algert Global LLC Sells 83,969 Shares of Immunovant, Inc. (NASDAQ:IMVT) - MarketBeat
Contrasting Immunovant (NASDAQ:IMVT) and enGene (NASDAQ:ENGN) - Defense World
Immunovant, Inc. (NASDAQ:IMVT) Receives $48.10 Average Target Price from Analysts - Defense World
Have Immunovant Insiders Been Selling Stock? - Simply Wall St
Immunovant, Inc. (NASDAQ:IMVT) Given Average Rating of "Buy" by Brokerages - MarketBeat
KBC Group NV Purchases 612 Shares of Immunovant, Inc. (NASDAQ:IMVT) - Defense World
Connor Clark & Lunn Investment Management Ltd. Sells 56,789 Shares of Immunovant, Inc. (NASDAQ:IMVT) - MarketBeat
Trend Tracker for (IMVT) - Stock Traders Daily
Immunovant, Inc. (NASDAQ:IMVT) CFO Sells $106,228.30 in Stock - MarketBeat
Insider Selling: Immunovant, Inc. (NASDAQ:IMVT) CEO Sells 16,692 Shares of Stock - MarketBeat
Immunovant CEO Peter Salzmann sells shares for $424,811 By Investing.com - Investing.com South Africa
Immunovant CFO Eva Renee Barnett sells $106,228 in stock By Investing.com - Investing.com South Africa
Immunovant CEO Peter Salzmann sells shares for $424,811 - Investing.com
Immunovant CFO Eva Renee Barnett sells $106,228 in stock - Investing.com
Immunovant, Inc. (NASDAQ:IMVT) Shares Bought by Victory Capital Management Inc. - Defense World
Victory Capital Management Inc. Has $9.56 Million Stake in Immunovant, Inc. (NASDAQ:IMVT) - MarketBeat
Why Is Immunovant, Inc. (IMVT) Among the Worst Performing Biotech Stocks in 2024? - Insider Monkey
Immunovant's Q2 Loss Wider Than Expected, Pipeline in Focus - MSN
Immunovant stock hits 52-week low at $24.66 amid market shifts - Investing.com Nigeria
Principal Financial Group Inc. Purchases 391,436 Shares of Immunovant, Inc. (NASDAQ:IMVT) - MarketBeat
(IMVT) Technical Data - Stock Traders Daily
FMR LLC's Strategic Acquisition of Immunovant Inc Shares - GuruFocus.com
Immunovant: Pipeline Progressing With One Minor Delay (NASDAQ:IMVT) - Seeking Alpha
Immunovant (NASDAQ:IMVT) Posts Earnings Results, Misses Expectations By $0.15 EPS - MarketBeat
Analysts Provide An Important Insights On Immunovant Inc (IMVT) - Stocks Register
Immunovant’s Strategic Advances in Autoimmune Therapies - TipRanks
Interesting IMVT Put And Call Options For March 2025 - Nasdaq
Immunovant's (IMVT) Buy Rating Reaffirmed at HC Wainwright - MarketBeat
2.88%
2.65%
大文字化:
|
ボリューム (24 時間):